| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d6f7da1e425c8a3ef1da21e08f4c196 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2014-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6459f602b5b76a494993d834a1e9dc1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629ab56601904a9e6aadcf54c4d34b27 |
| publicationDate |
2016-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3082838-A1 |
| titleOfInvention |
Methods and compositions for treating and preventing cognitive dysfunction |
| abstract |
The disclosure relates to methods and compositions for preventing or treating cognitive dysfunction. The methods comprise administering an effective amount of an aromatic-cationic peptide to subjects in need thereof. Specifically, the aromatic-cationic peptid has the formula D-Arg-2',6'-Dmt-Lys-Phe-NH2, and the cognitive dysfunction is associated with a reduced cerebral metabolic rate of oxygen (CMRO). |
| priorityDate |
2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |